|
Volumn 10, Issue 11, 2011, Pages 2025-
|
Lapatinib: Functional genomics study leads to insights into mechanism of action
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANASTROZOLE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FATTY ACID;
G PROTEIN COUPLED RECEPTOR 120;
GROWTH FACTOR RECEPTOR;
HORMONE RECEPTOR;
LAPATINIB;
LETROZOLE;
PROTEIN KINASE B;
TRASTUZUMAB;
APOPTOSIS;
BREAST CANCER;
CANCER CELL;
CANCER INHIBITION;
CELL CYCLE REGULATION;
CELL DEATH;
CLINICAL TRIAL (TOPIC);
DRUG EFFECT;
DRUG MECHANISM;
ENZYME INHIBITION;
ENZYME PHOSPHORYLATION;
FATTY ACID METABOLISM;
FUNCTIONAL GENOMICS;
GENE EXPRESSION PROFILING;
GLYCOLYSIS;
HUMAN;
MICROARRAY ANALYSIS;
MOLECULAR INTERACTION;
PRIORITY JOURNAL;
PROTEIN INDUCTION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
QUINAZOLINES;
|
EID: 81055127500
PISSN: 15357163
EISSN: 15388514
Source Type: Journal
DOI: 10.1158/1535-7163.MCT-11-0700 Document Type: Short Survey |
Times cited : (1)
|
References (0)
|